INTEGRATIVE APPROACH TO THE DIAGNOSIS AND TREATMENT OF VULVAR CANCER
DOI:
https://doi.org/10.5281/zenodo.20344029Keywords:
vulvar cancer, integrative oncology, gynecologic oncology, molecular diagnostics, immunotherapy, radiotherapy, multidisciplinary treatment.Abstract
Vulvar cancer is a rare gynecologic malignancy associated with significant physical and psychological complications. This article evaluates modern integrative approaches to the diagnosis and treatment of vulvar cancer. The study was based on analysis of scientific literature, clinical guidelines, and peer-reviewed oncology research. The findings demonstrated that multidisciplinary management improves early diagnosis, accurate staging, individualized treatment planning, and postoperative rehabilitation. Advanced imaging, molecular diagnostics, organ-preserving surgery, sentinel lymph node biopsy, radiotherapy, immunotherapy, and psychosocial support contribute to better oncologic and functional outcomes. Integrative oncology enhances patient quality of life and supports personalized treatment strategies.
References
1.Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. International Journal of Gynecology and Obstetrics. 2015;131:S76–S83.
2.Woelber L, Mahner S, Voelker K, et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Research. 2019;39(10):5453–5460.
3.Te Grootenhuis NC, van der Zee AGJ, van Doorn HC, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROINSS-V studies. Journal of Clinical Oncology. 2016;34(15):1829–1837.
4.Rogers LJ, Cuello MA. Cancer of the vulva. International Journal of Gynecology and Obstetrics. 2018;143(S2):4–13.
5.Nooij LS, Brand FA, Gaarenstroom KN, et al. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Critical Reviews in Oncology/Hematology. 2016;106:1–13.
6.Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database of Systematic Reviews. 2017.
7.Gadducci A, Tana R, Barsotti C, Guerrieri ME, Genazzani AR. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. Critical Reviews in Oncology/Hematology. 2012;83(1):71–83.
8.Oonk MHM, Planchamp F, Baldwin P, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer. International Journal of Gynecological Cancer. 2017;27(4):832–837.
9.Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2021;71(3):209–249.
10.Fons G, Groenen SM, Oonk MHM, et al. Adjuvant radiotherapy in vulvar cancer. Gynecologic Oncology. 2020;157(2):420–427.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal